Varma Mutual Pension Insurance Co Invests $13.92 Million in Ventas, Inc. $VTR

Varma Mutual Pension Insurance Co purchased a new stake in shares of Ventas, Inc. (NYSE:VTR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 156,768 shares of the real estate investment trust’s stock, valued at approximately $13,921,000.

A number of other large investors have also recently modified their holdings of VTR. NewEdge Advisors LLC grew its stake in Ventas by 856.1% in the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares in the last quarter. Empowered Funds LLC increased its holdings in Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after purchasing an additional 536 shares during the period. Woodline Partners LP raised its position in Ventas by 46.8% during the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after purchasing an additional 11,739 shares in the last quarter. Focus Partners Wealth raised its position in Ventas by 130.4% during the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after purchasing an additional 12,233 shares in the last quarter. Finally, Gamco Investors INC. ET AL purchased a new stake in shares of Ventas in the 2nd quarter worth $805,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Insider Activity at Ventas

In other news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 0.53% of the stock is currently owned by company insiders.

Ventas Price Performance

Shares of VTR stock opened at $93.32 on Monday. Ventas, Inc. has a 1-year low of $66.38 and a 1-year high of $101.60. The stock’s 50-day moving average is $91.36 and its 200 day moving average is $87.15. The company has a market cap of $47.87 billion, a P/E ratio of 172.81, a PEG ratio of 2.15 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44.

Ventas (NYSE:VTR) last announced its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The business had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm’s revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.87 earnings per share. Research analysts predict that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on VTR shares. BMO Capital Markets increased their price target on Ventas from $105.00 to $107.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. Evercore restated an “outperform” rating and issued a $95.00 price objective on shares of Ventas in a report on Wednesday, April 29th. UBS Group upped their price objective on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research note on Monday, May 4th. Cantor Fitzgerald increased their target price on shares of Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Finally, Wells Fargo & Company raised their target price on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $98.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.